| Pacific Endometriosis And Pelvic Surgery | |
|
11505 Burnham Dr Ste #302 Gig Harbor WA 98332 | |
| (253) 313-5997 | |
| (253) 313-5179 |
| Full Name | Pacific Endometriosis And Pelvic Surgery |
|---|---|
| Speciality | Clinic/Center |
| Location | 11505 Burnham Dr, Gig Harbor, Washington |
| Authorized Official Name and Position | Cindy Marie Mosbrucker (OWNER) |
| Authorized Official Contact | 2533135997 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pacific Endometriosis And Pelvic Surgery 11505 Burnham Dr Ste #302 Gig Harbor WA 98332 Ph: (253) 313-5997 | Pacific Endometriosis And Pelvic Surgery 11505 Burnham Dr Ste #302 Gig Harbor WA 98332 Ph: (253) 313-5997 |
| NPI Number | 1508227448 |
|---|---|
| Provider Enumeration Date | 03/18/2016 |
| Last Update Date | 11/02/2023 |
| Medicare PECOS PAC ID | 5890081939 |
|---|---|
| Medicare Enrollment ID | O20160915001627 |
News Archive
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508227448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 60016675 (Washington) | Primary |
| Provider Name | Cynthia M Mosbrucker |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1467544460 PECOS PAC ID: 0143318832 Enrollment ID: I20080827000583 |
News Archive
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 1 days ago
| Provider Name | Sarah Huntington |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831531821 PECOS PAC ID: 2567699036 Enrollment ID: I20131209001777 |
News Archive
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 1 days ago
| Provider Name | Trista Marie Newville |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1528324712 PECOS PAC ID: 9830406461 Enrollment ID: I20190723003643 |
News Archive
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 1 days ago
| Provider Name | Crystal L Walker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962159020 PECOS PAC ID: 3678956141 Enrollment ID: I20220816001720 |
News Archive
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 1 days ago
News Archive
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26.
Revolutionary new CryoSTAT is here to put the fire out when it comes to hemorrhoids by treating them on contact with cold therapy which has a proven track record of providing instant relief with no mess.
In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
› Verified 1 days ago
Habor Healing Arts Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13214 150th Street Kp N, Gig Harbor, WA 98329 Phone: 253-851-3311 | |
Apollo Health Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5401 32nd Ave Ste 106, Gig Harbor, WA 98335 Phone: 248-346-2398 | |
Harbor Home Therapy & Wellness Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 708 135th St Nw, Gig Harbor, WA 98332 Phone: 402-721-9662 | |
Gig Harbor Ambulatory Surgery Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5801 Soundview Dr, Ste 150, Gig Harbor, WA 98335 Phone: 253-756-0888 Fax: 253-752-1704 | |
Harbor Pediatrics Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4700 Point Fosdick Dr Nw Ste 319, Gig Harbor, WA 98335 Phone: 253-853-3888 Fax: 253-853-7393 | |
Franciscan Digestive Care-gig Harbor Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4700 Point Fosdick Dr Nw, #308, Gig Harbor, WA 98335 Phone: 253-858-7019 Fax: 253-858-5435 | |
Laser Cosmetic Wellnes Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7901 Skansie Ave Ste 105, Gig Harbor, WA 98335 Phone: 253-858-2408 Fax: 253-432-4050 |